Keyphrases
Allergic Diseases
7%
Antihistamines
100%
Astemizole
7%
Caller
7%
Chlorpheniramine
7%
Confidence Interval
28%
Congenital Anomalies
7%
Dimetindene
7%
Exposure during Pregnancy
7%
Exposure Groups
7%
First Trimester
21%
Fold Increase
7%
Gestational Exposure
100%
Histamine H1 Receptor Antagonist
7%
Human Pregnancy
14%
Hydroxyzine
7%
Israeli
7%
Loratadine
100%
Major Anomalies
14%
Overall Rate
7%
Pregnancy Outcome
100%
Promethazine
7%
Prospective Controlled Trial
7%
Relative Risk
28%
Teratogen Information Services
7%
Teratogenic Risk
7%
Terfenadine
7%
Medicine and Dentistry
Allergy
7%
Astemizole
7%
Chlorphenamine
7%
Cohort Analysis
100%
Congenital Malformation
7%
Dimetindene
7%
First Trimester Pregnancy
21%
H1 Antagonist
7%
Histamine Antagonist
100%
Hydroxyzine
7%
Loratadine
100%
Promethazine
7%
Teratogenic Agent
7%
Terfenadine
7%
Pharmacology, Toxicology and Pharmaceutical Science
Allergy
7%
Antihistaminic Agent
100%
Astemizole
7%
Chlorphenamine
7%
Cohort Study
100%
Congenital Malformation
7%
Dimetindene
7%
Histamine H1 Receptor Antagonist
7%
Hydroxyzine
7%
Loratadine
100%
Promethazine
7%
Teratogenic Agent
7%
Terfenadine
7%
Biochemistry, Genetics and Molecular Biology